A Global Virtual Event NEOHEART 2020 5th INTERNATIONAL CONFERENCE Cardiovascular management of the neonate OCTOBER 27-30, 2020 ADVANCE PROGRAM #neoheart2020 neoheartsociety.org NEOHEART 2 0 2 0 GOES VIRTUAL We hope you and your family are safe and healthy during this difficult time. In the wake of the COVID-19 pandemic, we have paused how we traditionally host medical conferences. Our team has reimagined NeoHeart 2020 as an immersive, transformative virtual experience. The possibilities are endless. For the very first time in NeoHeart's history, we will be hosting our conference virtually. Join us as we take a step into the future. Log in and connect with a global audience. NEOHEART 2020 Cardiovascular Management of the Neonate a global virtual event October 27-30, 2020 Our promise: To deliver stimulating & insightful sessions, lively and engaging discussions, guaranteed to capture your attention. Meet hundreds of your peers from around the world. Engage with more than 100 leading experts in the field. Collaborate, Seek solutions, Share ideas, & Participate. Join the Conversation. This October. register at neoheartsociety.org NEOHEART 2020 A MESSAGE FROM THE A GLOBAL NEONATAL HEART SOCIETY VIRTUAL EVENT We hope you and your family are well. OCT.27-30, 2020 The Neonatal Heart Society in partnership with Columbia University and New York Presbyterian's Morgan Stanley Children's Hospital, is proud to host NeoHeart 2020. Our hope was to host NeoHeart in Manhattan in New York City as a live- in-person event. Due to the pandemic, the Society and its partners have re- imagined the conference as a global virtual event. Other aspects of NeoHeart have not changed. NeoHeart remains a conference like no other. At NeoHeart, we disrupt silos and build bridges so that we can learn from each other. At NeoHeart, you share ideas. You question norms. You challenge dogma. Ganga Krishnamurthy MBBS And you find common ground with an expert in another President, Neonatal Heart Society field. You hear what new idea is pushing the field forward. What novel therapy is emerging on the horizon. Most importantly, you have ready access to experts from many specialities. Help build a world where This is what makes a truly fulfilling and successful every newborn infant conference. with cardiopulmonary disease receives optimal NeoHeart provides a venue for this experience. care for a healthier future Whether through workshops or critical thinking during case and panel discussions, each attendee will be pushed to think outside the box. Attendees will walk away with new ideas, tools and the potential to be part of a a leading-edge team at their Center. Join us in the virtual world! What NeoHeart is about NeoHeart is the flagship annual conference of the Neonatal Heart Society. We bring together clinicians, leading experts, thought leaders and researchers across the global scientific community to exchange new knowledge & share the latest research on neonatal cardiopulmonary disorders. Why you should attend NeoHeart 2020? the latest in science & cutting-edge research Learn new ideas and tools Expand yout network meet a global audience Experience a virtual conference- content you want, when you want Exchange ideas Gain insight from over 100 experts Who attends NeoHeart NeoHeart? by the numbers 538 Attendees at NeoHeart 2019 Neonatologists, pediatric cardiologists, cardiac surgeons, pediatric cardiac intensivists, pediatric intensivists, anesthesiologists, basic scientists, nurses, 15 advancedpractice providers, perfusionists, pharmacists, nutritionists, sonographers, Countries at NeoHeart 2019 respiratory therapists, Residents, Fellows and many more! The NeoHeart Experience: The only international conference dedicated to neonates with cardio-pulmonary disease NEOHEART 2020 CONFERENCE SCIENTIFIC ORGANIZING COMMITTEE Objectives Formulate an evidence based approach for optimal treatment of neonatal cardiopulmonary disorders including latest therapies. Know recent advances in the management of neonates with Hypoplastic left heart syndrome. Know novel therapeutic options available for the Ganga Krishnamurthy MBBS closure of a hemodynamically significant PDA in President, Neonatal Heart Society preterm infants including with percutaneous Associate Professor of Pediatrics transcatheter interventions. Medical Director, Infant Cardiac Unit Know how to manage term and preterm New York-Presbyterian Morgan Stanley neonates with persistent pulmonary hypertension Children's Hospital Columbia University Irving Medical Center, physiology or pulmonary hypertension secondary New York to BPD. Know how to monitor for development of pulmonary vein stenosis in preterm infants and therapeutic options available. Formulate an evidence based approach to diagnosis, monitoring and management of neonatal circulation and shock states. Describe the up-to-date basic science behind cardiopulmonary disorders. Emile Bacha MD Know the latest in neonatal resuscitation Chief, Division of Cardiac, Thoracic science. and Vascular Surgery New York-Presbyterian/ Know the latest advances and future Columbia University Medical Center, New York perspectives on Neonatal ECMO. Know current outcomes of preterm neonates with congenital heart disease and treatment options including non-surgical interventions. Know how to formulate an evidence based approach to providing optimal nutrition and developmentally appropriate care to preterm infants with congenital heart disease. Know modifiable and non-modifiable factors that influence neurodevelopmental outcomes in Richard A Polin MD infants with congenital heart disease. Professor & Executive Vice Chair, Department of Pediatrics New York-Presbyterian/ Columbia University Medical Center, New York NEO HEART 2 0 2WORKSHOPS 0 & MASTERCLASSES NeoHeart 2020 I Oct 27-30, 2020 I a global virtual event I COPYRIGHT NEONATAL HEART SOCIETY NeoHeart 2020 I Oct 27-30, 2020 I a global virtual event I COPYRIGHT NEONATAL HEART SOCIETY 12:30 PM US EST- 2:30 PM US EST 12:30 PM US EST- 2:30 PM US EST 12:30 PM US EST- 2:30 PM US EST NeoHeart 2020 I Oct 27-30, 2020 I a global virtual event I COPYRIGHT NEONATAL HEART SOCIETY NEOHEART 2020 KEYNOTE SPEECH KEYNOTE SPEAKER: RICHARD A JONAS MD The Neonatal Heart Society recognizes Dr Richard A Jonas for his extraordinary accomplishments and legendary career as a pediatric cardio-thoracic surgeon. Dr. Jonas is the Chief of Cardiac Surgery and the Co-Director of the Children's National Heart Institute at the Children's National Health System, Washington, DC. Richard A Jonas MD Reflections on a career in congenital cardiac surgery OCTOBER 27, 2020, 3:00- 3:30 PM US EST ABOUT RICHARD JONAS KEYNOTE SPEAKER: RICHARD A JONAS MD OCTOBER 27, 2020, 3:00- 3:30 PM US EST Dr. Jonas joined the staff of Children's National Medical Center in 2004 as the Chief of Cardiovascular Surgery, Co-Director of the Children's Heart Institute and Cohen Funger Professor of Cardiac Surgery. He undertook his general surgical training at the Royal Melbourne Hospital in Melbourne Australia and subsequently his cardiothoracic surgical training at Royal Children's Hospital in Melbourne and Green Lane Hospital in Auckland New Zealand. After fellowships at the Brigham and Women's Hospital and Children's Hospital Boston he was appointed to the Department of Surgery at Harvard Medical School in 1984. In 1994 Dr. Jonas was appointed to the William E Ladd Chair of Surgery at Harvard Medical School and became the Cardiovascular Surgeon in Chief at Children's Hospital Boston. Dr. Jonas has an active clinical practice in congenital cardiac surgery. He also maintains his own NIH supported laboratory research program in addition to his administrative responsibilities. He is the author of over 400 peer-reviewed publications and 2 textbooks. In addition to his responsibilities at Children’s Hospital Dr Jonas is a consultant to the FDA and has participated in numerous study sections of the NIH. He has worked with Project Hope for more than 25 years in establishing pediatric heart surgery in Shanghai, China as well as helping with the design and development of the Shanghai Children’s Medical Center. In 2005/6 Dr Jonas was the President of the American Association for Thoracic Surgery and in 2009/10 was President of the Congenital Heart Surgeon’s Society of North America. He was President of the World Society for Pediatric and Congenital Heart Surgery from 2016-2018. NEOHEART 2020 KEYNOTE SPEECH KEYNOTE SPEAKER: OLA DIDRIK SAUGSTAD MD, PHD The Neonatal Heart Society recognizes Dr Saugstad for his extraordinary accomplishments and legendary career as a neonatologist and a physician scientist. Dr. Saugstad is a Professor of Pediatrics at the University of Oslo, Norway. Fighting for Air How pure oxygen to term infants was abandoned in the delivery room OCTOBER 29, 2020, 3:00- 3:30 PM US EST ABOUT OLA DIDRIK SAUGSTAD MD, PHD KEYNOTE SPEAKER: OLA DIDRIK SAUGSTAD MD, PHD OCTOBER 29, 2020, 3:00- 3:30 PM US EST Dr Saugstad is a Professor in Pediatrics and served as the Director & Head of the Department of Pediatric Research at the University of Oslo and Oslo University Hospital from 1991 to 2017. He served as a Consultant in Neonatology at Oslo University Hospital, Rikshospitalet from 1986 to 2017. Since 2018, Dr Saugstad serves as an adjunct Professor at the Ann and Robert H Lurie Children’s Hospital of Chicago in the Northwestern University Feinberg School of Medicine. Dr Saugstad received his MD, PhD degrees from the University of Oslo, completed residency in Pediatrics in 1984 at the Oslo University Hospital where he also started his career as a neonatologist. Dr Saugstad was a research Fellow at the University of Uppsala (1973-74), and the Fogarty Fellow at the University of California, San Diego (1980-81) and a Visiting Research Associate at the University of California San Francisco (1986). During his career, he also served as the Head of the Norwegian Newborn Screening Program and served as the Head of the Department of Women and Child Health. Dr Saugstad has 505 publications recorded in PubMed, with more than 12 000 citations (web of knowledge). H index: (Web of Knowledge) 56, (Google scholar) 77.